Skip to content

Clinical trials

Inflammatory Bowel Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Country / region: South Korea Clear all

57 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20101
20115
20121
20133
20143
20152
20164
20174
20189
20191
20206
20215
20222
20233
20244
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed24
Recruiting11
Terminated11
Unknown status7
Active, not recruiting2
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Janssen Research & Development, LLC5
Eli Lilly and Company4
Yonsei University4
Kyunghee University Medical Center3
Pfizer3
Seoul National University Hospital3
Takeda3
Theravance Biopharma3
Asan Medical Center2
GlaxoSmithKline2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases57
Colitis, Ulcerative31
Crohn Disease27
Colitis6
Gastrointestinal Diseases2
Anxiety Disorders1
Arthritis, Rheumatoid1
Biliary Tract Neoplasms1
Colonic Neoplasms1
Duodenal Neoplasms1

Trials

Showing 1 to 25 of 57. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.